Technology news and discussion on TalkFuse.
Watchdog examines NHS claims of benefits from Palantir data platform
NHS England says 29 hospital trusts are realising benefits from Palantir’s £330m Federated Data Platform, but those trusts told freedom of information researchers that the system was not live or that they were using none of its applications. A senior health official called the gap “very misleading”, raising questions about the evidence used to support the controversial contract.
The NHS says 137 trusts are live with the platform and has attributed 117,539 additional operations in a year to trusts using it, while acknowledging it cannot prove the system caused the increase. The statistics watchdog is taking the benefits claim forward as casework. MPs and campaigners are urging ministers to end Palantir’s deal, with one committee chair calling for the 2027 break clause to be used and an open competition for a UK-based supplier.
In short
- 29 trusts say the platform is not live or is not being used.
- NHS England links the platform to 117,539 more operations, but cannot prove causation.
- MPs and campaigners are calling for scrutiny of Palantir’s contract.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
The NHS can reasonably argue that a shared data platform may help hospitals coordinate care and use capacity more efficiently, and that reported increases in operations are encouraging even if causation cannot yet be established. With many trusts said to be live, the contract may offer value if its benefits are measured transparently and shortcomings are addressed.
The case against
Critics can argue that claims of benefits are not credible enough to justify a £330m contract when some trusts counted as benefiting say the system is not live or they use none of its applications. The NHS’s inability to show that the platform caused the increase in operations strengthens calls for independent scrutiny and for ministers to consider the break clause and an open competition.
Explained simply
The NHS Federated Data Platform is a digital system intended to help hospitals organise information such as patient lists, staff availability and waiting times. NHS England awarded the £330m contract to the US technology company Palantir, and hospitals can use a range of applications within the platform.
NHS England and individual hospital trusts are responsible for reporting how the system is being used and what benefits it brings. The Office for Statistics Regulation checks whether official statistics are trustworthy and clearly explained, while MPs scrutinise public spending and government decisions.
The debate matters because the contract involves substantial public money and claims that the platform can help hospitals deliver more care. Comparing national figures with reports from individual trusts raises questions about how use and benefits are measured.
AI Business Health Medicine Technology UK World
Read the full article at the source →
Originally published by The Guardian as “Palantir AI tech unused or little used by 29 NHS trusts said to be benefiting from it”.